Chirag Shah

Chirag Shah has a diverse and extensive work experience history. Chirag is currently serving as the VP of R&D/Product Development at Anodyne Nanotech, Inc. Prior to this role, they held the position of Vice President of R&D Engineering and Quality Systems at Arch Therapeutics from 2014 to 2021. Chirag also has experience working at Covidien (Medtronic Minimally Invasive Therapies Group) as a Sr. Director of R&D, where they achieved notable accomplishments in the development of vascular embolization technologies. Before joining Covidien, they worked at Biolink Corp as a Technical Programs Manager and at C.R.Bard as a Sr. Project Engineer. Throughout their career, Chirag has demonstrated expertise in various areas, including neurovascular implants, thrombosis treatment, venous insufficiency, and renal access. Chirag has also received recognition for their achievements, such as the Covidien 2013 Early Stage Technology Innovation Award and the R&D Manager of the Year Award. Overall, Chirag Shah's work experience showcases their extensive knowledge and contributions to the field of medical technology and product development.

Chirag Shah has a diverse education history. Chirag obtained a Bachelor of Science degree in Chemical Engineering from L.D. College of Engineering in 1987. Following this, they pursued a Master of Science degree in Chemical Engineering from the University of Rhode Island, completing it in 1990. Chirag then continued their academic journey and obtained a Ph.D. in Chemical Engineering from the same institution in 1993. In 2009, they expanded their expertise by completing a Management and Leadership Certificate from MIT Sloan School of Management. Finally, in 2010, they obtained an Executive Leadership Certificate from Cornell University. No information is available about their education prior to attending L.D. College of Engineering.